Search

Jonathan Stuart Kaplan

Examiner (ID: 15168)

Most Active Art Unit
2836
Art Unit(s)
2107, 2104, 2836
Total Applications
226
Issued Applications
203
Pending Applications
10
Abandoned Applications
13

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5710397 [patent_doc_number] => 20060051742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Novel assay for the separation and quantification of hemagglutinin antigens' [patent_app_type] => utility [patent_app_number] => 11/119631 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12661 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051742.pdf [firstpage_image] =>[orig_patent_app_number] => 11119631 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119631
Assay for the separation and quantification of hemagglutinin antigens May 1, 2005 Issued
Array ( [id] => 5799338 [patent_doc_number] => 20060034859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Naturally processed measles virus peptides eluted from class II HLA molecules' [patent_app_type] => utility [patent_app_number] => 11/116682 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27247 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034859.pdf [firstpage_image] =>[orig_patent_app_number] => 11116682 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/116682
Naturally processed measles virus peptides eluted from class II HLA molecules Apr 27, 2005 Abandoned
Array ( [id] => 232653 [patent_doc_number] => 07598078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Settings for recombinant adenoviral-based vaccines' [patent_app_type] => utility [patent_app_number] => 11/105725 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 38 [patent_no_of_words] => 18905 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598078.pdf [firstpage_image] =>[orig_patent_app_number] => 11105725 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/105725
Settings for recombinant adenoviral-based vaccines Apr 13, 2005 Issued
Array ( [id] => 4977221 [patent_doc_number] => 20070218453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Sensing Tool' [patent_app_type] => utility [patent_app_number] => 10/594612 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12961 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218453.pdf [firstpage_image] =>[orig_patent_app_number] => 10594612 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594612
Sensing Tool Mar 28, 2005 Abandoned
Array ( [id] => 5601806 [patent_doc_number] => 20060292151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'L-SIGN polymorphisms and methods involving use of same' [patent_app_type] => utility [patent_app_number] => 11/093117 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33339 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292151.pdf [firstpage_image] =>[orig_patent_app_number] => 11093117 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/093117
L-SIGN polymorphisms and methods involving use of same Mar 27, 2005 Abandoned
Array ( [id] => 4574157 [patent_doc_number] => 07829667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same' [patent_app_type] => utility [patent_app_number] => 10/593413 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 11481 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829667.pdf [firstpage_image] =>[orig_patent_app_number] => 10593413 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593413
Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same Mar 17, 2005 Issued
Array ( [id] => 5769522 [patent_doc_number] => 20050266015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide' [patent_app_type] => utility [patent_app_number] => 11/078654 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4745 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266015.pdf [firstpage_image] =>[orig_patent_app_number] => 11078654 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/078654
Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide Mar 10, 2005 Abandoned
Array ( [id] => 5705169 [patent_doc_number] => 20060194217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Method of genotyping and phenotyping hepatitis B viruses resistant to antiviral molecules' [patent_app_type] => utility [patent_app_number] => 11/077359 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14719 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194217.pdf [firstpage_image] =>[orig_patent_app_number] => 11077359 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/077359
Method of genotyping and phenotyping hepatitis B viruses resistant to antiviral molecules Mar 10, 2005 Abandoned
Array ( [id] => 606147 [patent_doc_number] => 07153512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors' [patent_app_type] => utility [patent_app_number] => 11/076353 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17444 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153512.pdf [firstpage_image] =>[orig_patent_app_number] => 11076353 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/076353
Bovine immunodeficiency virus (BIV) based vectors Mar 7, 2005 Issued
Array ( [id] => 7111205 [patent_doc_number] => 20050208660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors' [patent_app_type] => utility [patent_app_number] => 11/076190 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17446 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208660.pdf [firstpage_image] =>[orig_patent_app_number] => 11076190 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/076190
Bovine immunodeficiency virus (BIV) based vectors Mar 7, 2005 Issued
Array ( [id] => 33054 [patent_doc_number] => 07785877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors' [patent_app_type] => utility [patent_app_number] => 11/076399 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17415 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785877.pdf [firstpage_image] =>[orig_patent_app_number] => 11076399 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/076399
Bovine immunodeficiency virus (BIV) based vectors Mar 7, 2005 Issued
Array ( [id] => 5069054 [patent_doc_number] => 20070190155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Molecular programming of nanoparticle systems for an ordered and controlled sequence of events for gene-drug delivery' [patent_app_type] => utility [patent_app_number] => 10/591213 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15395 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190155.pdf [firstpage_image] =>[orig_patent_app_number] => 10591213 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591213
Molecular programming of nanoparticle systems for an ordered and controlled sequence of events for gene-drug delivery Mar 3, 2005 Abandoned
Array ( [id] => 863904 [patent_doc_number] => 07368118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus' [patent_app_type] => utility [patent_app_number] => 11/068710 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 13842 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368118.pdf [firstpage_image] =>[orig_patent_app_number] => 11068710 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/068710
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus Feb 27, 2005 Issued
Array ( [id] => 6958380 [patent_doc_number] => 20050214750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Compositions and methods for determining the replication capacity of a pathogenic virus' [patent_app_type] => utility [patent_app_number] => 11/052741 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 19751 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214750.pdf [firstpage_image] =>[orig_patent_app_number] => 11052741 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/052741
Compositions and methods for determining the replication capacity of a pathogenic virus Feb 3, 2005 Abandoned
Array ( [id] => 7097676 [patent_doc_number] => 20050130135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/051613 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 28241 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130135.pdf [firstpage_image] =>[orig_patent_app_number] => 11051613 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/051613
Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof Feb 3, 2005 Abandoned
Array ( [id] => 588227 [patent_doc_number] => 07435539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Typing of human enteroviruses' [patent_app_type] => utility [patent_app_number] => 11/042898 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15446 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 444 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435539.pdf [firstpage_image] =>[orig_patent_app_number] => 11042898 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/042898
Typing of human enteroviruses Jan 24, 2005 Issued
Array ( [id] => 5894804 [patent_doc_number] => 20060003343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Primer and probe design for efficient amplification and detection of HCV 3\' non-translating region' [patent_app_type] => utility [patent_app_number] => 11/040417 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6781 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003343.pdf [firstpage_image] =>[orig_patent_app_number] => 11040417 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040417
Primer and probe design for efficient amplification and detection of HCV 3' non-translating region Jan 20, 2005 Abandoned
Array ( [id] => 6088007 [patent_doc_number] => 20110217332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Chimpanzee Adenovirus Vaccine Carriers' [patent_app_type] => utility [patent_app_number] => 10/587389 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 26015 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10587389 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/587389
Chimpanzee adenovirus vaccine carriers Jan 17, 2005 Issued
Array ( [id] => 7172009 [patent_doc_number] => 20050203015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Angiogenesis regulation system' [patent_app_type] => utility [patent_app_number] => 11/022582 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6434 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203015.pdf [firstpage_image] =>[orig_patent_app_number] => 11022582 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/022582
Angiogenesis regulation system Dec 22, 2004 Issued
Array ( [id] => 7038909 [patent_doc_number] => 20050158343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus' [patent_app_type] => utility [patent_app_number] => 11/018177 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22605 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158343.pdf [firstpage_image] =>[orig_patent_app_number] => 11018177 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/018177
Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus Dec 20, 2004 Abandoned
Menu